Natera, Inc. (NTRA) Financials

NTRA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.5 billion 691.8 million
2023-09-30 1.4 billion 661.9 million
2023-06-30 1.2 billion 651.7 million
2023-03-31 1.3 billion 668.3 million

NTRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -67.7 million 48.9 million
2023-09-30 -38.7 million 57.7 million
2023-06-30 -87.4 million 44.5 million
2023-03-31 -92.5 million 40.7 million

NTRA Net Income

No data available :(

NTRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 879.0 million - 78.6 million
2023-09-30 936.6 million - 68.3 million
2023-06-30 735.9 million 282.3 million 71.1 million
2023-03-31 812.0 million 282.0 million 73.9 million

NTRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 119.3 million
2023-09-30 115.2 million
2023-06-30 113.7 million
2023-03-31 111.8 million

NTRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 9.5 million 83.0 million 161.4 million -
2023-09-30 9.1 million 77.2 million 154.7 million -
2023-06-30 9.0 million 78.2 million 152.5 million -
2023-03-31 11.6 million 82.3 million 149.6 million -

NTRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 311.1 million 151.2 million
2023-09-30 268.3 million 147.3 million
2023-06-30 261.4 million 143.1 million
2023-03-31 241.8 million 148.1 million

NTRA

Price: $96.98

52 week price:
36.90
98.82

Earnings Per Share: -3.78 USD

P/E Ratio: -15.59

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 659200

Ebitda: -23.3 million

Market Capitalization: 11.4 billion

Links: